A Randomized, Open-label, Crossover, Single Dose Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 5/1000 mg) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000mg, and to Evaluate the Effect of Food on the Pharmacokinetics of DA-1229_01 After Single Oral Administration in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 31 May 2017
At a glance
- Drugs Evogliptin/metformin (Primary) ; Evogliptin; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Dong-A ST
- 01 Dec 2014 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 29 Sep 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 26 Jun 2014 New trial record